How SCOTUS’ Affirmative Action Decision Could Reduce Diversity in Biopharma

The U.S. Supreme Court recently declared an end to race-conscious admission programs into colleges and universities, also known as affirmative action. This decision invalidated admissions programs at Harvard and the University of North Carolina that took race into consideration when selecting qualified applicants, effectively ending the consideration of race as a factor to admit students to higher education.